A Pfizer vaccine specifically for the highly contagious variant of Covid-19 Omicron will be ready in March, the company’s CEO Albert Bourla announced on Monday on the American network CNBC.
In fact, he said that the pharmaceutical industry has already started producing the doses. “This vaccine will be ready in March,” Dr. Bourla told CNBC. “We are already starting to produce some of these quantities.”
The Greek CEO even pointed out that the vaccine will target the other variants that are circulating.
He clarified that it is not yet clear whether or not a vaccine is needed for Omicron or how it will be used, but Pfizer will have some doses ready, as some countries want it ready as soon as possible.
“The hope is that we will achieve something that will have much, much better protection, especially from infections, because protection from hospitalization and serious illness – is quite good at the moment, with the current vaccines, as long as you have done, say the third installment “, Burla stated characteristically.
Follow Skai.gr on Google News
and be the first to know all the news
.
